Recent Quotes (30 days)

You have no recent quotes
chg | %

Vivione Biosciences Inc  

(Public, CVE:VBI.H)   Watch this stock  
Find more results for CVE:VBI
0.0000 (0.00%)
Oct 23 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.00 - 0.07
Open     -
Vol. 0.00
Mkt cap 618,730.00
P/E     -
Div/yield     -
EPS 0.00
Shares 40.79M
Beta 0.08
Inst. own     -

Key stats and ratios

Q2 (Jun '17) 2016
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -46.92% -24.83%
Return on average equity -66.56% -26.44%
CDP Score - -


Eight Greenway Plaza, Suite 1320
United States - Map
+1-713-4750321 (Phone)
+1-509-5617287 (Fax)

Website links


Vivione Biosciences Inc. is a technology and life sciences company. The Company is focused on rapid bacterial detection. The Company has developed a diagnostic system called RAPID-B, which tests bacteria in critical environments and provides quantitative results in approximately seven hours or less. Its RAPID-B is an integrated microbiology/infectious disease diagnostic system. Its primary targeting is accomplished with custom, optimized immuno-based reagents that are designed to target the cell surface of target bacteria without cross-reactivity to similar non-target bacteria. Its RAPID-B system has applications in various markets, including Hospitals, Universities and Clinics; testing system for bacterial detection and antimicrobial susceptibility profiles for bacterial infection in normally sterile body fluids, such as blood and urine, and detecting the presence of bacteria in blood and urine samples within minute's and days.

Officers and directors

Kevin Kuykendall Chief Executive Officer, Director
Chester J. Jachimiec Chief Financial Officer
Steve Roon Senior Vice President - Sales and Marketing
James Hendren Director
Glenn William Vincent Smith Director
Philip A Tuttle Director
Age: 72
Ian E. Gallie Independent Director